Osaic Holdings
CUE icon

Osaic Holdings’s Cue Biopharma CUE Stock Holding History

Osaic Holdings’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51K Buy
48
+38
+380% +$859 ﹤0.01% 7356
2026
Q1 		$69 Sell
10
-13
-57% -$121 ﹤0.01% 7658
2025
Q4 		$209 Hold
23
– – ﹤0.01% 7574
2025
Q3 		$512 Hold
23
– – ﹤0.01% 7547
2025
Q2 		$463 Hold
23
– – ﹤0.01% 7364
2025
Q1 		$618 Buy
23
+10
+77% +$371 ﹤0.01% 6949
2024
Q4 		$414 Hold
13
– – ﹤0.01% 7059
2024
Q3 		$288 Hold
13
– – ﹤0.01% 7113
2024
Q2 		$471 Hold
13
– – ﹤0.01% 6999
2024
Q1 		$718 Buy
13
+11
+550% +$776 ﹤0.01% 6750
2023
Q4 		$164 Hold
2
– – ﹤0.01% 7065
2023
Q3 		$143 Hold
2
– – ﹤0.01% 7191
2023
Q2 		$273 Hold
2
– – ﹤0.01% 7156
2023
Q1 		$202 Sell
2
-67
-97% -$6.39K ﹤0.01% 7266
2022
Q4 		$6K Sell
69
-1,540
-96% -$141K ﹤0.01% 6185
2022
Q3 		$107K Buy
1,609
+317
+25% +$27.3K ﹤0.01% 4305
2022
Q2 		$96K Buy
1,292
+19
+1% +$2.22K ﹤0.01% 4454
2022
Q1 		$2.41M Buy
1,273
+386
+44% +$81.8K ﹤0.01% 1781
2021
Q4 		$301K Sell
887
-154
-15% -$59.6K ﹤0.01% 3562
2021
Q3 		$455K Buy
1,041
+360
+53% +$126K ﹤0.01% 3122
2021
Q2 		$237K Buy
681
+134
+24% +$51.9K ﹤0.01% 3724
2021
Q1 		$200K Buy
547
+543
+13,575% +$223K ﹤0.01% 3733
2020
Q4 		$2K Hold
4
– – ﹤0.01% 6047
2020
Q3 		$2K Hold
4
– – ﹤0.01% 5833
2020
Q2 		$3K Hold
4
– – ﹤0.01% 5646
2020
Q1 		$2K Buy
+4
New +$1.94K ﹤0.01% 5657

Other funds holding CUE

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM

Osaic Holdings's CUE Position: Q2 2026 in Review

Osaic Holdings increased its Cue Biopharma (CUE) stake by 380% in Q2 2026, buying an estimated $859 and bringing the position to 48 shares worth $1.51K. The position accounts for ﹤0.01% of the portfolio, ranked #7356.

Osaic Holdings first reported a position in CUE in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.41M in Q1 2022. 49 funds tracked by Wall St. Rank hold CUE as of Q2 2026.

  • Osaic Holdings held 48 shares of Cue Biopharma worth $1.51K as of Q2 2026.
  • Osaic Holdings bought 38 Cue Biopharma shares in Q2 2026, an estimated $859.
  • Cue Biopharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7356 holding.
  • Osaic Holdings first reported a position in Cue Biopharma in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Cue Biopharma position peaked at $2.41M in Q1 2022.
  • 49 funds tracked by Wall St. Rank held Cue Biopharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.